Automated Antimicrobial Susceptibility Testing Market Size Projected to Reach USD 7.04 Billion by 2032

“According to a new report published by Introspective Market Research, Automated Antimicrobial Susceptibility Testing Market by Product Type, Method, and End User, The Global Automated Antimicrobial Susceptibility Testing Market Size Was Valued at USD 4.42 Billion in 2023 and is Projected to Reach USD 7.04 Billion by 2032, Growing at a CAGR of 5.3% from 2024–2032.”

The Automated Antimicrobial Susceptibility Testing (AST) market plays a critical role in modern clinical diagnostics by enabling rapid and accurate determination of microbial resistance to antimicrobial agents. Automated AST systems significantly reduce turnaround time compared to conventional manual methods, helping clinicians make timely treatment decisions while minimizing the misuse of antibiotics.

These systems are widely adopted in hospitals, diagnostic laboratories, and research institutions to combat the growing challenge of antimicrobial resistance (AMR). Automated AST solutions offer improved standardization, higher throughput, reduced human error, and seamless integration with laboratory information systems.

With increasing incidences of infectious diseases, rising awareness of AMR, and growing investments in advanced diagnostic technologies, the Automated Antimicrobial Susceptibility Testing market is witnessing steady growth across both developed and emerging healthcare markets.

Market Segmentation

The Automated Antimicrobial Susceptibility Testing Market is segmented into Product Type, Method, and End User.
By Product Type, the market is categorized into Instruments, Consumables, and Software & Services.
By Method, the market is categorized into Phenotypic Methods, Genotypic Methods, and Hybrid Methods.
By End User, the market is categorized into Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Research Institutes.

Growth Driver

The primary growth driver for the Automated Antimicrobial Susceptibility Testing market is the rising global burden of antimicrobial resistance. Increasing cases of multidrug-resistant infections have intensified the need for rapid, reliable, and standardized susceptibility testing solutions. Automated AST systems enable early detection of resistant pathogens, supporting effective clinical decision-making and infection control. Additionally, government initiatives promoting antimicrobial stewardship programs and stricter regulatory guidelines for antibiotic usage are further accelerating the adoption of automated testing solutions across healthcare facilities worldwide.

Market Opportunity

A major market opportunity lies in the expansion of automated AST solutions in emerging economies. Rapid healthcare infrastructure development, rising diagnostic awareness, and increasing investments in laboratory automation in regions such as Asia-Pacific and Latin America are creating favorable growth prospects. Furthermore, technological advancements such as AI-enabled AST platforms, compact automated systems for smaller laboratories, and integration with digital health ecosystems are expected to unlock new revenue streams and broaden market penetration over the forecast period.

Detailed Segmentation

Automated Antimicrobial Susceptibility Testing Market, Segmentation

The Automated Antimicrobial Susceptibility Testing Market is segmented on the basis of Product Type, Method, and End User.

Product Type

The Product Type segment is further classified into Instruments, Consumables, and Software & Services. Among these, the Consumables sub-segment accounted for the highest market share in 2023. Consumables such as reagent kits, panels, and cartridges are used routinely for each test, leading to recurring demand. Their consistent usage across high-volume diagnostic laboratories and hospitals ensures steady revenue generation, making consumables a dominant segment in the overall market.

Method

The Method segment is further classified into Phenotypic Methods, Genotypic Methods, and Hybrid Methods. Among these, the Phenotypic Methods sub-segment held the largest market share in 2023. Phenotypic testing remains the gold standard for AST due to its reliability in measuring actual microbial response to antibiotics. Automated phenotypic systems offer faster turnaround times, improved accuracy, and cost-effectiveness, driving widespread adoption in routine clinical diagnostics.

Some of The Leading/Active Market Players Are-

• bioMérieux SA (France)
• Becton, Dickinson and Company (USA)
• Thermo Fisher Scientific Inc. (USA)
• Danaher Corporation (USA)
• Abbott Laboratories (USA)
• Siemens Healthineers AG (Germany)
• Bruker Corporation (USA)
• Accelerate Diagnostics, Inc. (USA)
• Liofilchem S.r.l. (Italy)
• Alifax S.r.l. (Italy)
• Hardy Diagnostics (USA)
• Bio-Rad Laboratories, Inc. (USA)
• HiMedia Laboratories (India)
• Nissui Pharmaceutical Co., Ltd. (Japan)
• QuidelOrtho Corporation (USA)
and other active players.

Key Industry Developments

In March 2024, a leading diagnostics company launched an advanced automated AST platform designed to deliver faster results with improved accuracy.
The new system integrates AI-driven analytics and enhanced data management capabilities, enabling laboratories to optimize workflows while supporting antimicrobial stewardship initiatives.

In October 2023, a global healthcare organization expanded its automated AST product portfolio through a strategic acquisition.
This acquisition strengthened the company’s presence in emerging markets and enhanced its capabilities in rapid infectious disease diagnostics.

Key Findings of the Study

• Consumables dominate the market due to recurring usage
• Phenotypic methods remain the preferred testing approach
• North America leads the market, followed by Europe
• Rising antimicrobial resistance is a key growth driver
• Automation and AI integration are major market trends

More Info:-­ https://introspectivemarketresearch.com/reports/automated-antimicrobial-susceptibility-testing-market/

About Us

At Introspective Market Research Private Limited, we are a forward-thinking research consulting firm committed to driving growth in the Automated Antimicrobial Susceptibility Testing Market. With deep insights, strategic solutions, and holistic research, we empower businesses to achieve success and dominance in the global Automated Antimicrobial Susceptibility Testing industry.

📞 Contact Us
Introspective Market Research Pvt. Ltd.
Phone: +91-91753-37569
Email: sales@introspectivemarketresearch.com
Web: www.introspectivemarketresearch.com